buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
All listed companies/Sanofi Consumer Healthcare India Limited
03 /Listed universe · Healthcare · Pharmaceuticals

Sanofi Consumer Healthcare India Limited.

Value itCompareScreener.in ↗Tijori ↗NSE ↗BSE ↗
Snapshot

Healthcare · Pharmaceuticals

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.

Market cap
₹9,186 cr
P/E (TTM)
34.5
P/B (latest)
26.4
ROE (TTM)
62.5%
ROCE (TTM)
51.4%
Sales CAGR 3y
16.5%
PAT CAGR 3y
13.3%
Debt / equity
0x
Promoter
71.3%
Dividend yield
1.88%
Size
Micro
Codes
SANOFICONR · 544250
Price

₹3,976.2 · 28 Sept 2026

1M
−5.6%
3M
−13.9%
6M
−2.7%
YTD
−12.8%
1Y
−20.1%
3Y
—
5Y
—
vs 52w high
−20.9%

52-week ₹3,945.3 – ₹5,026.8 · ADTV ₹3.5 cr · price-only.

Trend

Sales and net profit by fiscal year, ₹ crore

Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ